LYB
41
2
MCHP
54
13
EQT
54
-3
HIG
70
2
HCP
70
2
JNPR
50
4
MMC
65
3
PX
78
2
MTCH
50
8
SO
59
6
PLD
61
5
TSN
40
-2
CNP
65
2
MU
42
6
PNC
67
3
MCO
80
5
OMC
64
2
GM
72
3
RRC
58
-2
SPG
56
-4
LYB
41
2
MCHP
54
13
EQT
54
-3
HIG
70
2
HCP
70
2
JNPR
50
4
MMC
65
3
PX
78
2
MTCH
50
8
SO
59
6
PLD
61
5
TSN
40
-2
CNP
65
2
MU
42
6
PNC
67
3
MCO
80
5
OMC
64
2
GM
72
3
RRC
58
-2
SPG
56
-4
Financhill
Back

Editas Medicine Vs. EyePoint Pharmaceuticals Industry Stock Comparison

Sell
41

EDIT
Editas Medicine

Last Price:
2.21
Seasonality Move:
13.73%
Buy
64

EYPT
EyePoint Pharmaceuticals

Last Price:
9.01
Seasonality Move:
28.93%
Sell
41
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $2.38. The Score for EDIT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $9.23. The Score for EYPT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • EYPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $2.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $9.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 31.96 Sell
Chaikin Money Flow: -3498554 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.6 - 3.24) Sell
Bollinger Bands (100): (2.94 - 4.74) Sell

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 43.77 Sell
Chaikin Money Flow: -412789 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.32 - 11.82) Sell
Bollinger Bands (100): (8.14 - 10.52) Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.5 Sell
20-day SMA: 2.84 Sell
50-day SMA: 3.18 Sell
200-day SMA: 5.19 Sell
8-day EMA: 2.53 Sell
20-day EMA: 2.78 Sell
50-day EMA: 3.17 Sell
200-day EMA: 4.95 Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.12 Buy
20-day SMA: 10.61 Sell
50-day SMA: 9.78 Sell
200-day SMA: 13.36 Sell
8-day EMA: 9.32 Sell
20-day EMA: 9.95 Sell
50-day EMA: 9.91 Sell
200-day EMA: 11.44 Sell

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.41 per share, and an increase next year of $0.38 per share.

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):